Suhee Shin, the former head of Novartis Korea, is coming back to head another Korean subsidiary of a multinational pharmaceutical company after two and a half years.

According to industry sources, Director Suhee Shin, who had been leading the Healthcare Innovation Cluster at Roche Korea, has been appointed to take over as the General Manager of Amgen Korea following the retirement of the current GM, Sang-kyung Noh.

Shin resigned in 2022 when Novartis Korea's specialty drug and anticancer business units were merged as one and the current president, Byung-Jae Yoo took over as head of the new combined Novartis Korea. Since then, Shin joined Roche in February 2023.

She left R